Diaceutics PLC Diaceutics - Capital Markets Event
06 Giugno 2024 - 8:00AM
RNS Regulatory News
RNS Number : 2891R
Diaceutics PLC
06 June 2024
Diaceutics - Capital Markets
Event - Wednesday, 12 June 2024
Belfast and London, 6 June 2024 - Diaceutics PLC
(AIM: DXRX), a leading technology and solutions
provider to the pharma and biotech industry, will host a virtual Capital Markets Event for analysts and
investors on Wednesday, 12 June 2024 at 1400-1600 BST (0900-1100
ET).
The event will include presentations
from senior Diaceutics managers and partners. The purpose of the
event will be to give analysts and investors a deeper insight into
the DXRX platform, its functionality and hear from partners as to
how they use the platform to find patients.
Those wishing to attend can register
using the following link:
https://us02web.zoom.us/webinar/register/WN_WNsaZ-s8SfauitOYaWjdLA
Enquiries:
|
Diaceutics
PLC
|
|
|
Ryan Keeling, Chief Executive
Officer
Nick Roberts, Chief Financial
Officer
|
Tel: +44 (0)28 9040 6500
investorrelations@diaceutics.com
|
|
|
|
|
Stifel
Nicolaus Europe Limited (Nomad &
Broker)
|
Tel: +44 (0)20 7710 7600
|
|
Ben Maddison
|
|
|
Nick Harland
|
|
|
Kate Hanshaw
|
|
|
|
|
|
Alma Strategic
Communications
|
Tel: +44(0)20 3405 0205
|
|
Caroline Forde
Kinvara Verdon
Kieran Breheny
|
diaceutics@almastrategic.com
|
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease
outcome.
We provide the world's leading pharma
and biotech companies with an end-to-end commercialisation solution
for precision medicines through data analytics, scientific and
advisory services enabled by our platform DXRX - The Diagnostics
Network ®.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCUPUBWQUPCGAA
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Diaceutics (LSE:DXRX)
Storico
Da Nov 2023 a Nov 2024
